Immunomodulation of Melanoma by Chemo-Thermo-Immunotherapy Using Conjugates of Melanogenesis Substrate NPrCAP and Magnetite Nanoparticles: A Review.
chemo-thermo-immunotherapy
drug delivery system
heat shock protein
immune checkpoint inhibitor
in situ vaccine therapy
magnetite nanoparticle
melanogenesis
melanoma
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
09 Jun 2022
09 Jun 2022
Historique:
received:
01
05
2022
revised:
31
05
2022
accepted:
07
06
2022
entrez:
24
6
2022
pubmed:
25
6
2022
medline:
28
6
2022
Statut:
epublish
Résumé
A major advance in drug discovery and targeted therapy directed at cancer cells may be achieved by the exploitation and immunomodulation of their unique biological properties. This review summarizes our efforts to develop novel chemo-thermo-immunotherapy (CTI therapy) by conjugating a melanogenesis substrate,
Identifiants
pubmed: 35742905
pii: ijms23126457
doi: 10.3390/ijms23126457
pmc: PMC9223671
pii:
doi:
Substances chimiques
Magnetite Nanoparticles
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
J Invest Dermatol. 1987 May;88(5):538-40
pubmed: 3572026
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Jul;9(4):
pubmed: 28160445
Biochem Pharmacol. 1998 Jun 15;55(12):2023-9
pubmed: 9714323
J Biomed Biotechnol. 2009;2009:457936
pubmed: 19830247
Cancer Sci. 2003 Mar;94(3):308-13
pubmed: 12824927
Arch Dermatol. 1991 Oct;127(10):1528-34
pubmed: 1929460
J Invest Dermatol. 1999 Dec;113(6):928-34
pubmed: 10594732
J Biol Chem. 2000 Jul 14;275(28):21094-8
pubmed: 10781588
Science. 1997 Oct 3;278(5335):117-20
pubmed: 9311915
J Med Chem. 1984 Oct;27(10):1354-7
pubmed: 6481771
Biochem Pharmacol. 2012 Sep 1;84(5):646-53
pubmed: 22728921
Cancer Res. 1994 May 15;54(10):2661-6
pubmed: 8168094
J Dermatol Sci. 2012 Jul;67(1):51-60
pubmed: 22622238
Nat Commun. 2019 Jul 26;10(1):3349
pubmed: 31350406
Nature. 1988 Aug 4;334(6181):395-402
pubmed: 3043226
Immunity. 1998 Jun;8(6):657-65
pubmed: 9655479
Dev Biol. 1974 Jan;36(1):8-23
pubmed: 4822842
Cancer Immunol Immunother. 1998 Dec;47(4):198-204
pubmed: 9875672
Cancer Sci. 2010 Sep;101(9):1939-46
pubmed: 20594194
Cancer Res. 1987 Jun 15;47(12):3278-84
pubmed: 3107807
Science. 2006 Sep 29;313(5795):1960-4
pubmed: 17008531
Lab Invest. 2017 Jun;97(6):649-656
pubmed: 28263292
Jpn J Cancer Res. 1998 Jul;89(7):775-82
pubmed: 9738985
Int J Cancer. 1990 Nov 15;46(5):931-4
pubmed: 2121652
J Invest Dermatol. 1993 Feb;100(2 Suppl):231S-238S
pubmed: 8433013
Exp Dermatol. 2011 Feb;20(2):92-6
pubmed: 21255087
Biochem J. 1991 Dec 15;280 ( Pt 3):721-5
pubmed: 1764036
Eur Radiol. 2003 Jun;13(6):1266-76
pubmed: 12764641
J Biomed Mater Res A. 2019 Aug;107(8):1702-1712
pubmed: 30920169
J Immunother. 2009 Feb-Mar;32(2):129-39
pubmed: 19238011
Cancer Immunol Immunother. 2006 Mar;55(3):320-8
pubmed: 16133113
Chem Res Toxicol. 2009 Aug;22(8):1398-405
pubmed: 19610592
J Invest Dermatol. 2009 Sep;129(9):2233-41
pubmed: 19295615
Biochem Pharmacol. 1987 Jun 15;36(12):2007-11
pubmed: 3109434
J Invest Dermatol. 2011 Jun;131(6):1240-51
pubmed: 21326294
J Dermatol Sci. 2014 Mar;73(3):209-15
pubmed: 24315204
Nanomedicine (Lond). 2014 Aug;9(11):1715-26
pubmed: 25321171
Biochem Pharmacol. 1997 May 15;53(10):1435-44
pubmed: 9260870
Pigment Cell Res. 2000 Aug;13(4):222-9
pubmed: 10952389
Arch Dermatol Res. 1987;279(4):219-25
pubmed: 3674957
Int J Mol Sci. 2020 Aug 25;21(17):
pubmed: 32854423
Cancer Sci. 2007 Mar;98(3):424-30
pubmed: 17270032
Prostate. 2008 May 15;68(7):784-92
pubmed: 18302228
Cancer. 2000 Jul 15;89(2):399-403
pubmed: 10918172
Adv Mater. 2021 Jan;33(4):e2004788
pubmed: 33289219
Jpn J Cancer Res. 1996 Nov;87(11):1179-83
pubmed: 9045948
Nanomedicine (Lond). 2013 Jun;8(6):891-902
pubmed: 23066648
J Am Acad Dermatol. 2022 Mar;86(3):515-524
pubmed: 34915056